Hartington Pharmaceutical - Areas we work in

Highly acute and chronic respiratory diseases (rhinosinusitis, otitis and pharyngitis) and dermatological complaints (herpes zoster, herpes simplex eczema, fungi and acne) have been the focus of our research up until now.

We already have Nasodren® (whose active principle is Cyclamen Europeaum extract), a radically new treatment to combat rhinosinusitis and other respiratory diseases. Thanks to an innovative mechanism of action, it has become an effective safe alternative to antibiotics, providing relief from the symptoms and a cure for those affected without the need for surgical intervention (more than 2 million units sold worldwide) or multiple treatments (more than 3-4 treatments associated with the habitual clinical practise).

Awaiting the launch of Lazolex®, in Dermatology and Faringoforte® in the Respiratory area (ENT).

The introduction of Hartington products in other medical ﬁelds, such as Oncology, Rheumatology and Orthopaedic Surgery, is also expected.